Detalhe da pesquisa
1.
Development and Validation of an Enzyme Immunoassay for Detection and Quantification of SARS-CoV-2 Salivary IgA and IgG.
J Immunol
; 208(6): 1500-1508, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35228262
2.
Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron Variants.
J Infect Dis
; 228(3): 235-244, 2023 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36883903
3.
Severe Acute Respiratory Syndrome Coronavirus 2 Infection History and Antibody Response to 3 Coronavirus Disease 2019 Messenger RNA Vaccine Doses.
Clin Infect Dis
; 76(10): 1822-1831, 2023 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36578137
4.
Spike Gene Target Amplification in a Diagnostic Assay as a Marker for Public Health Monitoring of Emerging SARS-CoV-2 Variants - United States, November 2021-January 2023.
MMWR Morb Mortal Wkly Rep
; 72(5): 125-127, 2023 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36730050
5.
Early Detection and Surveillance of the SARS-CoV-2 Variant BA.2.86 - Worldwide, July-October 2023.
MMWR Morb Mortal Wkly Rep
; 72(43): 1162-1167, 2023 Oct 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37883327
6.
Epidemiologic, Immunologic, and Virus Characteristics in Patients With Paired Severe Acute Respiratory Syndrome Coronavirus 2 Serology and Reverse-Transcription Polymerase Chain Reaction Testing.
J Infect Dis
; 225(2): 229-237, 2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34216468
7.
Surveillance and Correlation of Severe Acute Respiratory Syndrome Coronavirus 2 Viral RNA, Antigen, Virus Isolation, and Self-Reported Symptoms in a Longitudinal Study With Daily Sampling.
Clin Infect Dis
; 75(10): 1698-1705, 2022 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-35442437
8.
Evaluating the Presence of Replication-Competent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From Nursing Home Residents With Persistently Positive Reverse Transcription Polymerase Chain Reaction (RT-PCR) Results.
Clin Infect Dis
; 74(3): 525-528, 2022 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33988220
9.
Neutralizing Antibody Response to Pseudotype Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Differs Between mRNA-1273 and BNT162b2 Coronavirus Disease 2019 (COVID-19) Vaccines and by History of SARS-CoV-2 Infection.
Clin Infect Dis
; 75(1): e827-e837, 2022 08 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34928334
10.
Relationship of SARS-CoV-2 Antigen and Reverse Transcription PCR Positivity for Viral Cultures.
Emerg Infect Dis
; 28(3): 717-720, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35202532
11.
Household Transmission and Symptomology of Severe Acute Respiratory Syndrome Coronavirus 2 Alpha Variant among Children-California and Colorado, 2021.
J Pediatr
; 247: 29-37.e7, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35447121
12.
Shedding of Culturable Virus, Seroconversion, and 6-Month Follow-up Antibody Responses in the First 14 Confirmed Cases of Coronavirus Disease 2019 in the United States.
J Infect Dis
; 224(5): 771-776, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33693830
13.
Changes in Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Over Time in 10 Sites in the United States, March-August, 2020.
Clin Infect Dis
; 73(10): 1831-1839, 2021 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33639620
14.
Seroprevalence of SARS-CoV-2 Among Frontline Healthcare Personnel During the First Month of Caring for Patients With COVID-19-Nashville, Tennessee.
Clin Infect Dis
; 72(9): 1645-1648, 2021 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32628750
15.
A Comparison of Less Invasive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Diagnostic Specimens in Nursing Home Residents-Arkansas, June-August 2020.
Clin Infect Dis
; 73(Suppl 1): S58-S64, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33909063
16.
Comparison of Estimated Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Through Commercial Laboratory Residual Sera Testing and a Community Survey.
Clin Infect Dis
; 73(9): e3120-e3123, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33300579
17.
Clinical and Laboratory Findings in Patients With Potential Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection, May-July 2020.
Clin Infect Dis
; 73(12): 2217-2225, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33598716
18.
Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Reactive Antibodies: December 2019-January 2020.
Clin Infect Dis
; 72(12): e1004-e1009, 2021 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33252659
19.
Epidemiologic Characteristics Associated With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Antigen-Based Test Results, Real-Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) Cycle Threshold Values, Subgenomic RNA, and Viral Culture Results From University Testing.
Clin Infect Dis
; 73(6): e1348-e1355, 2021 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33846714
20.
A Prospective Cohort Study in Nonhospitalized Household Contacts With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Symptom Profiles and Symptom Change Over Time.
Clin Infect Dis
; 73(7): e1841-e1849, 2021 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32719874